Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhagef. Am J Ophthalmol. 1990;109:33–7.
Article CAS PubMed Google Scholar
Al-Hity A, Steel DH, Yorston D, Gilmour D, Koshy Z, Young D, et al. Incidence of submacular haemorrhage (SMH) in Scotland: a Scottish Ophthalmic Surveillance Unit (SOSU) study. Eye. 2019;33:486–91.
Article CAS PubMed Google Scholar
Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762–73.
Article CAS PubMed Google Scholar
Ohji M. Submacular hemorrhage: my personal journey to the goal. Graefes Arch Clin Exp Ophthalmol. 2025;263:901–8.
Confalonieri F, Ferraro V, Barone G, Di Maria A, Petrovski BÉ, Vallejo Garcia JL, et al. Outcomes in the treatment of subretinal macular hemorrhage secondary to age-related macular degeneration: a systematic review. J Clin Med. 2024;13:367.
Article CAS PubMed PubMed Central Google Scholar
Ibanez HE. Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol. 1995;113:62.
Article CAS PubMed Google Scholar
Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A. Pneumatic displacement of submacular hemorrhage. Indian J Ophthalmol. 2007;55:451–5.
Fujikawa M, Sawada O, Miyake T, Kakinoki M, Sawada T, Kawamura H, et al. Comparison of pneumatic displacement for submacular hemorrhages with gas alone and gas plus tissue plasminogen activator. Retina. 2013;33:1908–14.
Article CAS PubMed Google Scholar
McKibbin M, Papastefanou V, Matthews B, Cook H, Downey L. Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration. Eye. 2010;24:994–8.
Article CAS PubMed Google Scholar
The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477.
Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209-13.e2.
Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15-22.e2.
Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data. Ophthalmology. 2020;127:616–36.
Cho SC, Cho J, Park KH, Woo SJ. Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age‐related macular degeneration. Acta Ophthalmol (Copenh). 2021;99:e706–14.
Cho JH, Ryoo N-K, Cho KH, Park SJ, Park KH, Woo SJ. Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy. Am J Ophthalmol. 2016;169:79–88.
Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg Visual Acuity Test. Investig Ophthalmol Vis Sci. 2006;47:1236.
Inoue N, Kato A, Araki T, Kimura T, Kinoshita T, Okamoto F, et al. Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: a retrospective multicenter survey. PLoS ONE. 2022;17:e0271447.
Article CAS PubMed PubMed Central Google Scholar
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Article CAS PubMed Google Scholar
Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, et al. Displacement of submacular hemorrhage using subretinal cocktail injection versus pneumatic displacement: a real-world comparative study. Ophthalmologica. 2024;247:118–32.
Article CAS PubMed PubMed Central Google Scholar
Kimura T, Araki T, Yasukawa T, Kato A, Kuwayama S, Kinoshita T, et al. Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by age-related macular degeneration and retinal macroaneurysms: a multicenter survey from the Japan Clinical Retina Study (J-CREST) group. PLoS ONE. 2022;17:e0274508.
Article CAS PubMed PubMed Central Google Scholar
Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, et al. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2011;249:1153–7.
Article CAS PubMed Google Scholar
Hosokawa MM, Ouchi C, Shiode Y, Kimura S, Matoba R, Morita T, et al. Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2024;262:3099–107.
Article CAS PubMed Google Scholar
Kitagawa Y, Shimada H, Mori R, Tanaka K, Wakatsuki Y, Onoe H, et al. One-year outcome of intravitreal tissue plasminogen activator, ranibizumab, and gas injections for submacular hemorrhage in polypoidal choroidal vasculopathy. J Clin Med. 2022;11:2175.
Article CAS PubMed PubMed Central Google Scholar
Wakabayashi T, Hara C, Shiraki A, Shiraki N, Sayanagi K, Sakimoto S, et al. Simultaneous intravitreal aflibercept and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2023;261:1545–52.
Article CAS PubMed Google Scholar
Chew GWM, Ivanova T, Patton N, Dhawahir-Scala F, Jasani KM, Turner G, et al. Step-wise approach to the management of submacular hemorrhage using pneumatic displacement and vitrectomy. Eye (Lond). 2023;37:1178–84.
Comments (0)